You are on page 1of 29

Reversed Phase HPLC

Chromatographic Process

Reversed Phase Advanced Features


Dr. Shulamit Levin
Analytical Department

B+A
Hydrophobic Stationary Phase

Mobile phase Water, Buffers MeOH, Acetonitril, IPA

Medtechnica
Email: levins @medtechnica .co.il shulal@zahav .net.il

A B Distribution: K = Cs /Cm B (More Hydrophobic)

Tel: 03-9254040 Cell: 052-448632 Fax: 03-9249977 Home page: http://www.forumsci.co.il/HPLC

A Elution through the Column Chromatogram

Reversed-Phase Chromatography
Non-polar stationary phase
O-S O-Si i OH O- Si O- Si OH O-Si OH O- Si O-Si O- Si OH O- Si O- Si

RP Method Development Tools

Polar mobile phase Analyte Y Non-Polar Analyte X Polar


Flow

low C18

Phenyl C4 Columns C8 CN

MeOH

pH Additives

Solvents MeCN THF

Well retained (like attracts like)

Poorly retained

high

Dr. Shulamit Levin, Medtechnica


levins@medtechnica.co.il

Reversed Phase HPLC


ELUTION ORDER IN REVERSED PHASE
1 R E S P O N S E 2 3
LIPOPHYLIC

3
0.30

Reversed Phase Elution Order


OH

2
CH 3

3
CH3
0.25

OH
0.20

CH3

O
AU 0.15

1
OH

2
OH

O
0.10

H3 C

H3C

VOID 1

OH
0.05

Methylparabene 2 3
OH
0.00
0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 2.00 2.20 2.40 2.60 2.80 3.00 3.20 3.40 3.60 3.80 4.00 4.20 4.40 4.60 4.80 5.00

OH

Propylparabene

OH

TIME (MIN.)

Minutes

PAH Analysis with Alliance System and PDA Using a Binary Gradient
UV@254nm Column- HibarRT 125-4 LiChrosphere PAH Eluent A: Water Eluent B: Acetonitrile Gradient: Linear A to B 11 minutes, Hold 10 minutes Back to initial conditions Flow Rate: 1.0 ml/min Injection: 20ul
11 5 2
0.06 0.04 0.02 0.00 4.00 6.00 8.00 10.00 12.00 Minutes 14.00 16.00 18.00 20.00

Hydrophobicity
3.0

6
0.16 0.14 0.12 0.10 AU 0.08

10 4 7 3 8 9 12 13 14 15

16

1- Naphthalene - 20 ppm 2- Acenaphthylene- 40 ppm 3- Acenaphthene- 20 ppm 4- Fluorene- 4 ppm 5- Phenanthrene- 2 ppm 6- Anthracene- 2 ppm 7- Fluoranthene- 4 ppm 8- Pyrene- 2 ppm 9- Benzo(a)anthracene- 2 ppm 10- Chrysene- 2 ppm 11- Benzo(b) fluoranthene- 4 ppm 12- Benzo(k) fluoranthene- 2 ppm 13- Benzo(a) pyrene- 2 ppm 14- Dibenzo(a,h) anthracene- 4 ppm 15- Benzo(g,h,I) perylene-4 ppm 16- Indeno(1,2,3-cd)pyrene-2 ppm

7 e

log k'

4
2.0

b a 3 1 c 2 d

1.0 1.0 2.0 3.0

log P

Dr. Shulamit Levin, Medtechnica


levins@medtechnica.co.il

Reversed Phase HPLC

ISOCRATIC vs GRADIENT
9

IONIZABLE
11
R4 R 1 N R3 R2
AMINES - 1,2,3,4

R E S P 0 O N S E

2 3 4 5

10

O C

CARBOXYLIC ACIDS

OH

VOID
NH R OH

9 1 2 3 4 5 67 8 10 11
OH R O S OH O
SULPHATES

ALCOHOLS

OH R O P OH O
PHOSPHATES

OH R P OH O
PHOSPHONATES

OH R S OH O
SULPHONATES

0 VOID

R SH
THIOLS

TIME (MIN.)

MOBILE PHASE
* * * * * * TYPE OF MODIFIER (MeOH, ACN) SOLVENT STRENGTH (% modifier) pH TYPE OF BUFFER (phosphate, acetate) IONIC STRENGTH (Salts, buffer concentration) ION-PAIRING REAGENTS (alkyl-amines, -sulfonates) * * * * * *

MOBILE PHASE
TYPE OF MODIFIER (MeOH, ACN)
SOLVENT STRENGTH (% modifier) pH TYPE OF BUFFER (phosphate, acetate) IONIC STRENGTH (Salts, buffer concentration) ION-PAIRING REAGENTS (alkyl-amines, -sulfonates)

Dr. Shulamit Levin, Medtechnica


levins@medtechnica.co.il

Reversed Phase HPLC


OPTIMIZATION: CHOICE OF SOLVENTS

MOBILE PHASE
* * TYPE OF MODIFIER (MeOH, ACN)

20% MeOH

SOLVENT STRENGTH (% modifier)


pH TYPE OF BUFFER (phosphate, acetate) IONIC STRENGTH (Salts, buffer concentration) ION-PAIRING REAGENTS (alkyl-amines, -sulfonates)

20% ACN

* *

20% EtOH

* *

20% THF

main solvent: H2 O

SOLVENT STRENGTH Analyte Retention as a Function of % Modifier

OPTIMIZATION: % SOLVENTS

20% MODIFIER

k (retention) for each analyte changes independently as % Modifier changes. Thus, the resolution between peaks changes.
ln k peak 8 peak 9 peak 10 peak 11

40% MODIFIER

60% MODIFIER

% Acetonitrile

80% MODIFIER

Dr. Shulamit Levin, Medtechnica


levins@medtechnica.co.il

Reversed Phase HPLC

MOBILE PHASE
* * * * * * TYPE OF MODIFIER (MeOH, ACN) SOLVENT STRENGTH (% modifier)

Ionization of Acids and Bases


Dissociation of Molecule

Acid HA
(Un-ionized) 50% 100% 0% @ pKa Low pH High pH

pH
TYPE OF BUFFER (phosphate, acetate) IONIC STRENGTH (Salts, buffer concentration) ION-PAIRING REAGENTS (alkyl-amines, -sulfonates)

+ A

(Ionized) 50% 0% 100%

Ionization of Acids and Bases


Dissociation of Molecule

Retention Factor versus pH for Acids, Basesand Neutrals

Retention Factor -Linear

Acids (HA)
( pKa =4.8 ) Un-Ionized
k =

k HA + k

a +

K [H ]

a +

B
Un-Ionized

Base B
(Un-ionized) 50% 0% 100% @ pKa Low pH High pH

K 1+ [H

Neutral

BH

+ OH

(Ionized) 50% 100% 0%

ABases (BH )
( pKa = 9.0 ) - Ionized +

Ionized

10 11 12 13 14

pH

Apparent pKa

Dr. Shulamit Levin, Medtechnica


levins@medtechnica.co.il

Reversed Phase HPLC


Resolution of Two Acidic Compounds at Different Mobile Phase pHs

Enhanced Resolution of Basic Compounds at High pH

Silica gel high pH limit

k versus pH
CH3

Amitriptyline

Capacity Factor (k)

pH 2
0 1 Minutes 2 3

Best retention

Decreasing retention Critical pH control necessary

Indoprofen

Ketoprofen
Silanols ionized

CH3

Amitriptyline

10

Nortriptyline

Amitriptyline
N H CH3

pH 8

Nortriptyline

pH control critical 2 Amitriptyline 3

Silanols Un-ionized

8 pH 2
Nortriptyline

Minutes

pH 2
0 1 Minutes 2 0

pH 8
1 Minutes 2

Nortriptyline

pH 10

Phoebe, Tran

pH

Minutes

Dependence of Selectivity on pH
23
0.115

Impact of pH on the Retention of a Zwitterionic Compound

5 4

pH 2.5
AU
6

0.115

12

3 4 5

Conditions: Column:

pH 5.0

AU

0.075

0.075

XTerra RP 18, 3.9 X 150 mm, 5 m Mobile Phase: 65% 20 mM Buffers, 35% ACN Column Temp.: 30 C Flow Rate: Detector: 1.0 mL/min 210nm for pH 2.5, pH 5.0, and pH 7.0; 230nm for pH 10.6

Aqueous pKa = 4.3

Aqueous pKa = 9.5


Negative Charge

0.035

0.035

6
4 8 12

-0.005 0

12

16

20

24

28

-0.005 0

Time (min)
0.135 0.121 0.107 0.093 0.079 0.025

Time (min)
16
0.015

Positive Charge

1 6 2

pH 8.0
AU
5 3 4
4 8 12 16 20

pH 10.6
2 53 4

AU

0.065 0.051 0.037 0.023 0.009 -0.005 0

1:acetaminophen 2:lidocaine 3:doxepin 4:imipramine 5:nortriptyline 6:ibuprofen

Dual Charge

pH
H N OH

0.005

-0.005 0

10

20

30

40

50

Time (min) Lu, Cheng; Waters

Time (min)

pH the most powerful selectivity tool

Fexofenadine (Antihistamine)
C H3 C H3 C OO -

+
HO

Dr. Shulamit Levin, Medtechnica


levins@medtechnica.co.il

Reversed Phase HPLC


UV/Vis Spectral Change Between Ionized and Non-ionized Forms
Typical Chromatograms for pH Failure of an Ordinary C18-Silica Column

1.00 1.20 1.00 0.80 AU 0.60 0.40 0.20 0.00 220 240 260 280 300 320 340 360 380 nm
252 277 286 216

2 4

Astemizole
254 nm pH 2.0 pH 10.0

0.80 0.60 0.40 0.20 0.00

Ketoconazole
3

Initial
5

254 nm pH 2.0 pH 10.0


293

1. Uracil 2. Propranolol 3. Naphthalene 4. Acenaphthene 5. Amitriptyline

1 2 4 5

After failure
3

220 240 260 280 300 320 340 360 380 nm

Phoebe, Tran

40 minutes

MOBILE PHASE
* * * * TYPE OF MODIFIER (MeOH, ACN) SOLVENT STRENGTH (% modifier) pH

Recommended Buffers for pHs 2-7


Additive or Buffer TFA Acetic Acid Acetate pK a pH range ( 1 pH unit) Volatile or NonVolatile Volatile Volatile Volatile Volatile/No n-volatile Volatile/No n-volatile Nonvolatile Nonvolatile Recommended for use with Extended pH Packings Yes (0.02 -0.1%) Yes (0.1 -1.0%) Yes (0.1 -1.0%) Yes (1-10mM) NH 4, Na, K Yes (1-10mM) NH 4, Na, K Yes No for pHs >7.0 (lower the
temperature the longer the column lifetime)

0.3 4.76 4.76 3.76 5.76 3.75 2.75 4.75 2.15 1.15 3.15 7.20 6.20 8.20

Formic Acid 3.75

TYPE OF BUFFER (phosphate, acetate) IONIC STRENGTH (Salts, buffer concentration)


ION-PAIRING REAGENTS (alkyl-amines, -sulfonates)

Formate Phosphate

*
*

Dr. Shulamit Levin, Medtechnica


levins@medtechnica.co.il

Reversed Phase HPLC


Types of Buffers and Ionic Strength

MOBILE PHASE
* * * TYPE OF MODIFIER (MeOH, ACN) SOLVENT STRENGTH (% modifier) pH TYPE OF BUFFER (phosphate, acetate) IONIC STRENGTH (Salts, buffer concentration)

pH 10: Borate
20 mM H 3 BO 3

pH 7: Phosphate
20 mM K 2HPO
4

pH 4-5: Acetate
10 mM CH
3

COONH

* * *

100 mM CH 3COOH

pH 2-3.5: Phosphate
20 mM H 3 PO4 - KH 2PO 4

ION-PAIRING REAGENTS (alkyl-amines, -sulfonates)

Ion Pair Reagent


Alkylamines
CH3CH2 Triethylamine (TEA) CH3CH2 N+ OHCH3CH2

Concentration of Ion-Pair Reagent in the Mobile Phase

Alkylsulfonates
Pentanesulfonate - Na+ SO 3 SO3 - Na+

The larger the alkyl, the longer are retention times


The larger alkyls saturate the stationary phase at lower concentrations

C8 C7 C6

CH2CH2 CH3 CH2 CH3CH2 CH2 CH2

Hexanesulfonate
OH-

N+ CH2CH2CH2CH3 CH2CH2CH2 CH3

Heptanesulfonate

SO3 Na+ SO 3- Na+ SO 3 Na+

k'

C5

Tetrabutylamine (TBA)

Octanesulfonate
H3C CH3CH2 CH2 CH2 OHN+ CH2CH2CH2CH3 CH3 Dibutyl -dimethylamine

Dodecylsulfonate

5 mM Conc. of Ion Pair Reagent in the Mobile Phase

Dr. Shulamit Levin, Medtechnica


levins@medtechnica.co.il

Reversed Phase HPLC


Stationary Phase Characterization
The Evolution of the Silica Gel Particle Platform

1960s 1970s 1980s 1990s 2000s

Pellicular native silica Irregular 10 m native silica Spherical 5 m native silica Spherical 3-5 m high purity silica Hybride Silica-Gel (co-polymer organic/Inorganic) high purity silica

Improvement in Peak Shape for Bases

neutral

Conventional C 18 base 1970's base Modern C18


Early 1990's

Not all C18s are the same!

neutral

base neutral

Embedded Polar Technology -- Today

neutral
0

base

Hybride Silica Technology -- Today


50

Time (min)

Dr. Shulamit Levin, Medtechnica


levins@medtechnica.co.il

Reversed Phase HPLC


Different Columns Different Chromatograms
7
V0 = 0.86 min

Different Columns Different Chromatograms


7
V0 = 1.05 min

3 4 5 6 8

Symmetry C 18
9 10

3 4 5

9 6 8

YMC Hydrosphere
10

1.00

2.00

3.00

4.00

5.00

6.00

7.00

8.00 9.00 Minutes

10.00

11.00 12.00

13.00

14.00 15.00

1.00

2.00

3.00

4.00

5.00

6.00

V0 = 0.92 min

2 3 4 5

7 6 8

9 10

SymmetryShield RP18
V0 = 0.93 min

7.00 8.00 Minutes

9.00

10.00

11.00

12.00

13.00

14.00

15.00

Phenomenex Luna
8 9 10

7 2 3 4 5 6

1
1.00 2.00 3.00

4.00

5.00

6.00

7.00 8.00 Minutes

9.00

10.00

11.00

12.00

13.00

14.00

15.00 1.00 2.00 3.00 4.00 5.00 6.00 7.00 8.00 Minutes 9.00 10.00 11.00 12.00 13.00 14.00 15.00

YMC ODS AQ
8 9 10

7
V0 = 1.00 min

V0 = 0.98 min

3 4 5

3 4 5 6

9 8

Phenomenex Aqua
10

1
7.00 8.00 Minutes 9.00 10.00 11.00 12.00 13.00 14.00 15.00

1.00

2.00

3.00

4.00

5.00

6.00

1.00

2.00

3.00

4.00

5.00

6.00

7.00 8.00 Minutes

9.00

10.00

11.00

12.00

13.00

14.00

15.00

Relative Ranking of C18 Columns Using a Standardized Test

Making a Bonded Phase Material: Monofunctional Synthesis

O n

OH Si O

H3 C Cl Si

C8 Silane Ligand
C C CH 3 C C C C C CH 3

There are no bad C18 columns. There are only different C18 columns.

Silica Gel Surface


O Si O O

H3 C Si O

C C CH 3

C C

C C

C CH 3

+ HCl

Dr. Shulamit Levin, Medtechnica


levins@medtechnica.co.il

10

Reversed Phase HPLC


Surface of a Silica Gel Bonded-Phase Packing Material
C8 alkyl chains
CH2 H 2C CH2 H 2C CH2 H 2C H3 C H O Si O O O H2 C residual silanol CH 2 Si O Si O CH 3 H 3C H O Si O CH 3 Si O CH 2 HC CH 3 3 H O Si O O O Si O Si O O CH 3 H O Si O O H2C CH 2 H2C CH 2 H2 C CH 2 H 2C CH 2 H 3C Si O Si O O

Stationary Phase Properties


H3C

H 3C

H3C CH 2

H3 C CH 2 H2 C CH 2

CH 2 H2C CH 2 H2C CH 2 H 2C CH 2 H 3C H O Si O O

CHEMISTRY: * BONDED HYDROCARBON: C-18, C-8, C-4, C-1, CN, phenyl * % COVERAGE * TYPE OF SILICA GEL
endcap
CH 3

CH 3

Si O Si

CH 3 H3C H O O O Si O H Si O Si O O

CH 3

GEOMETRY * SPHERE- IRREGULAR * PARTICLE DIAMETER * POROSITY

Si O O

Note: ~50% of the surface silanols remain even with high bonding densities

Stationary Phase Ligands


Stationary phase
C
18 8 2

Neutral Compounds: C18 versus C4 (Same Brand Different Ligands)

Functionality
Si(CH ) C H
3 2 18 37

Butylparaben

Note: Similar selectivity due to same silica particle.


Acenaphthene

Naphthalene

Si(CH ) C H
3 2 5 2 3 3 2 2 8

17

tC

SiC H
2

Aminopropyl Cyanopropyl Diol

Si(CH ) NH

Si(CH ) (CH ) CN
2 3

Si (CH 2 )3 O CH 2CH(OH)CH Retention time

OH
YMC-Pack Pro C18 YMC-Pack Pro C4 0 4 8 12 Minutes 16 20 24

Chain length CN Phenyl NH2 C4 C8 C18

Dr. Shulamit Levin, Medtechnica


levins@medtechnica.co.il

11

Reversed Phase HPLC

Type of Ligands

Reversed-Phase Packing with an Embedded Polar Ligand


Polar Group

O Si CH3 CH3

Embedded Polar Group Ligand

O Si CH3 CH3

Traditional, Straight Chain Alkyl Ligand

Commercial Phases with Embedded Polar Group

Embedded Polar Ligand: Possible Mechanism


Polar group increases water concentration in surface layer

Me Si Me O

O C N H R

SymmetryShield RP (Waters)
O H H
O C Si O Si O C H3 C C O C N H (CH 2)7 C H3

O Si N H C R Discovery RP Amide16 (Supelco)

O Si O O
O

OH3 C

Si
Me
- reduces

N H
Me Si Me

O C

N H

Prism, Spectrum (Keystone)

interaction with silanols selectivity water wettability


Me N H

O C R

- modifies - improves

Shields Negative Silanols


Bonus RP (Hewlett Packard)

No additional hydrophobic retention Reduced retention of bases Reduced peak tailing

Dr. Shulamit Levin, Medtechnica


levins@medtechnica.co.il

12

Reversed Phase HPLC

Embedded Polar Goups


Embedded Polar Wetted Surface
Water Water "Shield" "Shield" Layer Layer
O O

Mixed-Mode Retention:
Hydrophobic Interaction with Bonded Phase
O-Si O-Si OH O- Si O- Si OH O- Si OH O- Si O- Si O-Si OH O- Si O-Si

Ion exchange Interaction with Charged Sites


O- Si O- Si OO- Si O-Si + O- (CH ) HN 32 O- Si OO- Si O- Si O- Si OO-- Si O- Si

H N
C

H N
O C O

Water layer repels Carbon chain -- keeping ligand extended -- maintaining retention

Mobile Phase pH < 3

+ HN (CH 3 )

Embedded Polar Ligand versus Linear Alkyl Ligand on Silica Gel

Silica Surface

Si - OH

Me Si
Me O Si Me O C

Me

O
Me Si O

Me

Me Si O

Me O C O

H N

Mobile Phase pH > 3

Si O -

H N

Base

Base

Impact on Selectivity - Retention


Mobile Phase: 20 % CH 80 % pH 3 KH PO
2 3 4

CN Buffer

Amitriptyline SymmetryShield RP18 TF USP = 1.13


SymmetryShield RP 8

3 4 1 2 Sample: 1. Benzyl Alcohol 2. Phenol 3. Benzoic Acid 4. Benzylamine

3 4 1 2

Symmetry C18 TF USP = 1.95

Symmetry C

10
Time (minutes)

15

10 Minutes

20

30
B. A. Alden

Reduced Retention of Amines


(Shielding of Silanols )

Dr. Shulamit Levin, Medtechnica


levins@medtechnica.co.il

13

Reversed Phase HPLC


Selectivity Difference: Furazolidone Impurities
SymmetryShield RP8
0.01 0.01

Stationary Phase Properties


CHEMISTRY: * BONDED HYDROCARBON: C-18, C-8, C-4, C-1, CN, phenyl * % COVERAGE * TYPE OF SILICA GEL GEOMETRY * SPHERE- IRREGULAR * PARTICLE DIAMETER * POROSITY

Symmetry C8

0.008

0.008

0.006

0.006

0.004

0.004

0.002

0.002

-0.002 0 10 20 30

-0.002 0 10 20 30

El Fallah

minutes

minutes

CARBON LOAD
H3C

Surface of a Silica Gel Bonded-Phase Packing Material


H3C CH 2 H2C CH 2 H 2C CH2 H 2C H 2C CH2 CH 2 CH2 H 2C CH 2 H 2C H 3C CH 2 H 2C CH 2 H 3C CH 2

Increasing carbon load on a similar geometrical shaped particles increases retention.


O Si O

H 2C H3C H

CH 2 Endcap H2C H2 C Residual silanol H2 C CH2 CH2 CH 2 CH 3 CH 2 CH 3 3C H 3C H H 3 C H 3 C CH 3 H3 C CH 3 CH3 CH3 CH3 H Si CH 3 Si Si Si Si Si H H H H O H O O O O O O O O O O O Si Si Si Si Si Si Si Si Si Si O Si O O O O O O O O O O O O O O O O O O O O O CH 2

H2C

High Coverage High Ligand Density

Retention time
H3 C CH 2 H2 C CH 2

C8 alkyl chains
Polar analytes easily interact with surface

H 3C CH 2 H 2C CH 2 H 2C

Low Coverage Low Ligand Density

Carbon load 5% 7% 9% 12% 15% 17%


O Si O

H2 C H 2C H3C H CH 2

Residual silanols

CH 2 CH 3 CH 3 CH 3 H3 C Si CH 3 H CH3 H 3C Si Si H H O O O O O O Si Si Si Si Si Si O O O O O O O O O O O O

H O O Si O

CH 2 H2C Endcap CH 2 CH 3 H3 C CH 3 H 3C Si CH 3 Si H H O H O O O O Si Si Si O O O O Si O O O O

Dr. Shulamit Levin, Medtechnica


levins@medtechnica.co.il

14

Reversed Phase HPLC


Surface of a Silica Gel Bonded-Phase Packing Material

Silica based "bonded phases"

H 3C

C8 alkyl chains
CH2

H3C CH 2 H2C

H3 C CH 2 H2 C CH 2 CH 2 H2 C CH 2 CH 2 H 2C CH 2 CH 3 H 3C H O Si O O O Si O Si O O

H3C CH 2 H2C CH 2 H2C CH 2 H 2C CH 2 CH 3 H 3C H O Si O O Si O Si O CH 3 H3C H O O Si O H Si O Si O O O

H 2C CH2 H 2C CH2 H 2C H3 C H

H2C H2 C residual silanol

endcap
CH 3 CH 3

CH 2 Si O Si O O O O CH 3 H 3C H O Si O

CH 3 Si O

CH 2 HC CH 3 3 H O Si O O O Si O Si O

Bulky alkylsilane ligands can not react with all available silanols due to the steric hindrance.

O Si

Si O O

Note: ~50% of the surface silanols remain even with high bonding densities

Ligand Density (Surface Coverage)


=
2

Better Way to Compare: Ligand Density (Surface Coverage)


%C

Ligand Density (Surface Coverage)


moles/m Silica Silanols : Highest Bonding Reported : 6 -8 4.2

100

SA

nC

12

1 - %C 100

MW - 1 nC 12

moles/m

SA - Specific Surface Area MW - Molecular Weight of Ligand

%C % Carbon Load nC - # of Carbon Atoms in Ligand

Residual Silanols (Best Case)

2.0
[ ~ 30% ]

Ligand Density

Retention

Silanols

Residual Silanols (Typical)

> 3.5
[ > 50% ]

Surface Area

%C

Ligand Density

Dr. Shulamit Levin, Medtechnica


levins@medtechnica.co.il

15

Reversed Phase HPLC


Acidic Compounds:C18 versus C8 (Same Brand Different Ligand)
Relative Hydrophobicities of General Purpose Analytical Packings

Suprofe n Naproxen Fenoprofen

Diclofenac

Note: Similar selectivity due to same silica particle.

Inertsil ODS-2

Symmetry C18
Puresil C18 Zorbax Rx C18

Nova-Pak C18
Inertsil C8

Symmetry C8 YMC-Pack Pro C18 YMC-Pack Pro C8 Bondapak C18 0 4 8 Minutes 12 16 20 0 5 10 15


Zorbax Rx C8

Nova-Pak C8

k' acenapthene

Stationary Phase Properties


CHEMISTRY: * BONDED HYDROCARBON: C-18, C-8, C-4, C-1, CN, phenyl * % COVERAGE * TYPE OF SILICA GEL Native/Synthetic-Pure GEOMETRY * SPHERE- IRREGULAR * PARTICLE DIAMETER * POROSITY

Types of Silica
Silanols pH stability Metal content Temperature stability

Dr. Shulamit Levin, Medtechnica


levins@medtechnica.co.il

16

Reversed Phase HPLC

Structure of Silica Gel

What are Silanols?


Silanol (Si-O-H)
=H =O = Si

Silicon Oxygen

Amorphous, porous matrix of silicon atoms joined together with oxygen atoms to form siloxane bonds = (Si O Si)

Residual unreacted surface hydroxyl groups left over from polymerization Reactive sites for use in bonding ligands (C18) to the silica gel surface

Surface Silanols Found on Silica Gel


H H

Mixed-Mode Retention:
O O O Si O
Mobile Phase pH < 3

Vicinal (Bridged)

O O Si O
O

Hydrophobic Interaction with Bonded Phase


O-Si O-Si OH O- Si O- Si OH O- Si OH O- Si O- Si O-Si OH O- Si O-Si

Ion exchange Interaction with Charged Sites


O- Si O- Si OO- Si O-Si + O- (CH ) HN 32 O- Si OO- Si O- Si O- Si OO-- Si O- Si

HO OH O Si O Si O

OH O

O Si O

+ HN (CH 3 )

Si - OH

Geminal (Silanediol)

Mobile Phase pH > 3

OH

Si O -

Lone (most active)

O Si

O Si

Base

Base

Dr. Shulamit Levin, Medtechnica


levins@medtechnica.co.il

17

Reversed Phase HPLC


Bonded Phase on Particles Bonded Hybrid versus Bonded Silica Gel Surfaces

H3 C

C 18 H 37 C 18 H 37 CH 3 CH 3 H 3 C CH 3 H3 C CH 3 Si Si Si OH OH OH

C18-Bonded Silica Gel 1/2 -OSi(CH3)2R 1/2 -OH

CH3

C18 H37 CH3 CH3 H3 C CH3 H3 C Si Si OH CH3 OH

C18-Bonded Hybrid 1/3 -OSi(CH3)2R 1/3 -CH3 1/3 -OH

Silica Gel C18 Materials 1/2 free silanols

XTerra C18 Materials 1/3 free silanols

Hybrid versus Silica Gel Particle

PERFORMANCE BY ONE PEAK


ASYMMETRY FACTOR

Af =
RETENTION FACTOR or CAPACITY RATIO

B (10% h)
(10%

h)

Amitriptyline

k' =

tR - t 0 t0 t

k =

Cs Cm

TAILING FACTOR

Tf =
(5% h)

A+B 2A

Symmetry C18 TF USP = 1.95 XTerra MS C18 TF USP = 1.35 0 10 20 Minutes 30 40

NUMBER OF THEORETICAL PLATES

t0 w

N = 16

tR w

Dr. Shulamit Levin, Medtechnica


levins@medtechnica.co.il

18

Reversed Phase HPLC


Amitriptyline Peak Tailing Over Extended pH Range 1-12 Integration Errors Caused by Tailing

T = 1.00

T = 1.58 Recovered Peak Areas 97.8 % 95.3 % 92.3 %

Tailing Factor USP

Conventional C18

Recovered Peak Areas 99.9 % 99.8 %

Pure Silica C18


2

99.6 %

Ideal Tailing Factor


0 1 2 3 4 5 6 7 8

Hybrid C18

Buffer pH

10

11

12

Types of Silica
Silanols pH stability Metal content Temperature stability

pH Limitations of Silica Based Packing Materials

Hydrolysis of Bonded Ligand

pH

Dr. Shulamit Levin, Medtechnica


levins@medtechnica.co.il

19

Reversed Phase HPLC


Hydrolysis of a Bonded Phase Material: Monofunctional Ligand
Typical Chromatograms for Reference C18-Silica Column

O O Si O

OH

H3C Cl Si

C C C H3

C C

C C

C C H3

2 4

+
H3C Si Si O

Initial
3 5

C C CH 3

C C

C C

C CH 3

O O O

+ HCl
1 2 4 5

1. Uracil 2. Propranolol 3. Naphthalene 4. Acenaphthene 5. Amitriptyline

Low pH (hydrolysis of ligand)


OH

After failure
3

O O Si O

H3C Si HO

C C CH 3

C C

C C

C CH3

40 minutes

Types of Silica
Silanols pH stability Metal content Temperature stability

Metal Content in Silica Aluminum in the Silica Gel Lattice


Bronsted Acid
O Si Si HO O Si

3D top view of silica particle surface with silanols pointing upward


O O Si O Si OH O

H O
Al

Metal available for chelation

Dr. Shulamit Levin, Medtechnica


levins@medtechnica.co.il

20

Reversed Phase HPLC


Correlation Between Base Tailing and Aluminum Content of Silica Gel Correlation between Metal Content of Silica Gel and Peak Retention and Shape
Propranolo l Methanol Acenaphthene Naphthalene

Waters Symmetry C18


Amitriptylin e

Analyte: Chlorpheniramine Mobile Phase: Acetonitrile/KH2PO 4 pH 3.0 (20:80)


4

Butylparab en

Al conc.< 10 ppm TF USP = 1.95

Propranolol and Butylparaben

Tailing 3 Factor
2 1

"High Purity Silica Gel" Region

10

20 Minutes

30

40

Naphthalene

Waters Nova -Pak C18


Acenaphthene

Methanol

Al conc.= ~375 ppm TF USP = 6.5


Amitriptyline

100 200 300 Aluminum Content, ppm

400
5 15 Minutes 25

35

45

Peak Shapes of Chelating Agent (Hinokitiol)

Types of Silica
Silanols pH stability Metal content Temperature stability

Low metals

Mobile phase:20 mM MPhosphate = metal Buffer pH 3.6 with 0.05% EDTA: Acetonitrile (50:50)

O O Si O Mn+ O

Si

High metals
2 4 Minutes 6 8

Dr. Shulamit Levin, Medtechnica


levins@medtechnica.co.il

21

Reversed Phase HPLC


Temperature Effects on Resolution Effect of Temperature
(Isocratic separations)

Resolution can be temperature dependent

N=2250

60 0 C 50 0 C

1160 psi
Higher Temperature: Shorter Run Time Sharper Peaks Better Sensitivity Lower Back Pressure

Temperature can be a critical parameter to control in order to achieve reproducible separations.


N= 1680
1.00 2.00 3.00 4.00 5.00 6.00 7.00 8.00 9.00 10.00

40 0 C 30 0 C
Minutes

1920 psi

Effect of Temperature on Column Efficiency

Dependence of Retention on Temperature


0.024 0.022 0.020 0.018 0.016 0.014

0.024 0.022

1 2

300 C
AU

0.020 0.018 0.016 0.014 0.012 0.010

1 2

400 C
3

Conditions: Column:

Plate height, H [m]

35 30 5C 25 20 15 10 0 1 2 3 4 5 6 7 8 9 60C 25C

0.012 AU 0.010 0.008 0.006 0.004 0.002

0.008 0.006 0.004 0.002

XTerra MSC18, 2.1 X 50 mm, 2.6 m Mobile Phase: 25% ACN/75% buffer (10 mM, pH5, NH4AC) Flow Rate: 0.6 mL/min Injection Vol.3 L

0.000

0.000
-0.002 0.00 1.00 2.00 3.00 4.00 5.00 6.00 Minutes 7.00 8.00 9.00 10.00 11.00 12.00

-0.002 0.00

1.00

2.00

3.00

4.00

5.00

6.00 Minutes

7.00

8.00

9.00

10.00

11.00

12.00

Detector:

210 nm

0.024 0.022 0.020 0.018 0.016 0.014 0.012 0.010 0.008 0.006 0.004 0.002 0.000 -0.002 0.00

0.024

1 2

500 C
3
AU

0.022 0.020 0.018 0.016 0.014 0.012 0.010 0.008 0.006 0.004 0.002 0.000

1 2

600 C
3

Analyte Conc. (g/ml) 1: doxepin 0.5 2: imipramine 1.0 3: amitriptyline 3.0

AU

1.00

2.00

3.00

4.00

5.00

6.00 Minutes

7.00

8.00

9.00

10.00

11.00

12.00

-0.002 0.00

1.00

2.00

3.00

4.00

5.00

6.00 Minutes

7.00

8.00

9.00

10.00

11.00

12.00

Linear velocity, u [mm/s]

Lu, Cheng

Higher Temp. Shorter Run Time Higher Signal

Dr. Shulamit Levin, Medtechnica


levins@medtechnica.co.il

22

Reversed Phase HPLC


Temperature Effects on Resolution - Gradient

High Temperature Phosphate Buffer Test


0.10

1 4
0.10

0.300 0.200 AU 0.100 0.000 25.00

5, 6

Rs (5,6) = 0 Rs (8,9) = 2.39


7
30.00

10 9 8
35.00

30 C

Conditions - Column: Symmetry300,,C 5 m, 3.9x150mm


18 AU

Day 21

XTerra RP

Peak Number 1. 2. 3. 4.

USP Tailing Factor 1.2 1.1 1.1 1.0

18
AU

11

Minutes

40.00

- Sample: Tryptic digests of bovine cytochrome c - Injection: 20 L


- 0.005

3
- 0.005 4.00 5.00 Minutes 6.00 7.00 8.00 9.00 10.00 1.00 2.00 3.00

Doxepin Nortriptyline Amitriptyline Trimipramine

0.300 0.200 AU 0.100 0.000 25.00

5, 6

Rs (5,6) = 0 Rs (8,9) = 2.07


7
30.00

3
4.00 5.00 6.00 7.00 8.00 9.00 10.00

10 9 8 11

35 C

- Mobile Phase: Solvent A: 0.1% TFA in water Solvent B: 0.1% TFA in acetonitrile - Gradient: 0-45 min., 0-3 0 % B
40.00

1.00

2.00

3.00

0.48

0.26

Minutes

C 18 - silica particle
AU

Day 2
4

Minutes

35.00

0.300 0.200 AU 0.100 0.000 25.00

Rs (5,6) = 0.84 Rs (8,9) = 1.63


5 6 7
30.00

10 9 8 11

40 C

- Flow rate: 0.75 mL/min. - Detection: 214 nm

4 2
- 0.02

AU

3
0.00 5.00 Minutes 6.00 7.00 8.00 9.00 10.00 1.00 2.00 3.00

2
4.00 5.00 Minutes 6.00

3
7.00 8.00 9.00 10.00

1.00

2.00

3.00

4.00

Minutes

35.00

40.00

Tricyclic Antidepressant Separation

Stationary Phase Properties


CHEMISTRY: * BONDED HYDROCARBON: C-18, C-8, C-4, C-1, CN, phenyl * % COVERAGE * TYPE OF SILICA GEL GEOMETRY * SPHERE- IRREGULAR * PARTICLE DIAMETER * POROSITY

Spherical and Irregular particles

Electron microphotograph of spherical and irregular silica particles. [W.R.Melander, C.Horvath, Reversed-Phase Chromatography, in HPLC Advances and Perspectives, V2, Academic Press, 1980]

Dr. Shulamit Levin, Medtechnica


levins@medtechnica.co.il

23

Reversed Phase HPLC

Stationary Phase Properties


Resolution (Arbitrary Units)

Resolution - Time Diagram


90' s 80' s
12 10 8

CHEMISTRY: * BONDED HYDROCARBON: C-18, C-8, C-4, C-1, CN, phenyl * % COVERAGE * TYPE OF SILICA GEL GEOMETRY * SPHERE- IRREGULAR * PARTICLE DIAMETER * POROSITY

70' s

Length / dp 30 cm / 10 m 15 cm / 5 m 9 cm / 3 m

0 1 10 100 1000

Analysis Time [min]

Comparison of the van Deemter Plots for 5 m and 2.5 m XTerra MS C 18 Particles
(50/50, acetonitrile / water mobile phase)
30 28 26 24

Challenge of producing smaller particles


Contains a proportion of 2 m particles
Both are commercial 2m packings

22 20 18 16 14 12 10 8 6 4 2 0
Alden

5 m XTerra Particle

Smaller Particles Higher Flow Rate provide Shorter Run Time Higher Efficiency 2.5 m XTerra Particle

H (m)

Centered at 2.4 m Narrower distribution


4

0.5

Linear Velocity (mm/sec)

1.5

2.5

3.5

(Waters proprietary technology)

Dr. Shulamit Levin, Medtechnica


levins@medtechnica.co.il

24

Reversed Phase HPLC


Fast Gradient Application
Columns: XTerra MS C18 2.1 x 20 mm, 2.5 m; XTerra MS C18 2.1 x 50 mm, 5 m Mobile Phase: A = 0.1% TFA in water, B = 0.08% TFA in MeCN Gradient: 5 - 95% B in 45 seconds and 120 seconds Column Temperature: 60 C Flow Rate: 1.5 mL/min. Detector: 254 nm Injection Volume: 1 L 0.20 Column: XTerra MS C18

Fast Gradient of 12 Standards

2.1 x 20 mm, 2.5 m


Gradient 0 - 100% B in 2.5 min, A: 0.1% TFA in water B: 0.08% TFA in MeCN Flow rate: 1.5 mL/min Temperature: 60 C

0.50 0.40 0.30 AU 0.20

2.5 m 2.1 x 20 mm

AU 0.10

0.10 0.00 0.20 0.80 0.60 AU 0.40 0.20 0.00 0.20 0.40 0.60 0.80 1.00 Minutes 1.20 1.40 1.60 1.80 2.00 0.40 0.60
Minutes

0.80

1.00

1.20

1.40 0.00

5 m 2.1 x 50 mm

0.20

0.40

0.60

0.80

1.00

1.20

1.40

1.60

1.80

2.00

2.20

2.40

Minutes

Carmody

Fast LC/MS Applications


2.1 mm 5 m and 2.5 m columns length: 5 cm and 3 cm flow rates 0.2 and 0.6 mL/min Conditions:
n n n n n n n n 100

Fast LC-MS Analysis


XTerra MS C18, 2.1 x 50 mm ( 5 m)
N

2.56

295 8.11e4

100

295
N

4.59e4 296

(4)

0 100 1.57 280 2.21e5

0
N

100
O

(2)

280 1.13e5 281 264 233 265 260 9.25e4 7.67e4

HPLC: 65/35 0.1% formic acid / MeCN 1 L injection of 200 ng/mL of samples MS: ESI+; SIR 4 channels HV: 3.15 kV, Cone 25 V Drying Gas: 380 L/h Source Temp: 175oC

0 100 2.16 264 1.26e5

0 100
NH

(3)

0 100 1.29 260 1.53e5

0 100
O OH N H

(1)
0 100 125 150 175 200 225 250 Mass/Charge (m/z)

261 275 300

0 100 1.57 2.16 1.29 2.56 TIC 3.50e5

1.00

2.00

3.00

4.00

5.00

Ding

Time (min)

10 L injection of 200 ng/mL sample (in 40% MeOH),1= Propranolol, 2= Doxepin, 3= Nortriptyline, 4=Trimipramine, 65/35 0.1 % Formic Acid / MeCN 0.2 mL/min

Dr. Shulamit Levin, Medtechnica


levins@medtechnica.co.il

25

Reversed Phase HPLC


Masschromatograms of Std.10ppm (APcI +/- )
std.,
std_ A
. .

Fast LC-MS Analysis


XTerra MS C18: 5 m vs.. 2.5 m

ppm

Tinuvin 770DF

: Scan AP+ . . e

2
100 0.51 3 0.74 0.91

std_ A
. .

Chmassorb944LD
. . . . . . . . . . . . . . .

: Scan AP+ . . e

1
0.38

2.5 m

TIC 8.06e5

Relative Abundance (%)

std_ A

Tinuvin 326 % std_ A

: Scan AP. . e

2.1 x 30 mm 0.6 mL/min split 0.2 mL/min to MS 0 100

HPLC: 65/35 0.1% formic acid / MeCN 1 L injection of 200 ng/mL of samples MS: ESI+ SIR 4 channels HV: 3.15 kV Cone 25 V Drying Gas: 380 L/h Source Temp: 175oC 1= 2= 3= 4= Propranolol Doxepin Nortriptyline Trimipramine

2 1
1.13

1.44

3
2.04

4
2.44

Irganox 1076 +
% std_ A
. . . . .

. . . . . . . .

: Scan AP+ . . e

5 m
2.1 x 50 mm 0.2 mL/min

TIC 1.15e6

Irganox 1076 % . . . . . . . . .

: Scan AP. . e

0.50

1.00

1.50

2.00

2.50

3.00

3.50

4.00

4.50

Time . . .

Ding

Time (min)

Stationary Phase Properties


CHEMISTRY: * BONDED HYDROCARBON: C-18, C-8, C-4, C-1, CN, phenyl * % COVERAGE * TYPE OF SILICA GEL GEOMETRY * SPHERE- IRREGULAR * PARTICLE DIAMETER * POROSITY

Pore size, shape and distribution

Macroporous spherical silica particle. [K.K.Unger, Porous silica, Elsevier , 1979]

Pore size defines an ability of the analyte molecules to penetrate inside the particle and interact with its inner surface. This is especially important because the ratio of the outer particle surface to its inner one is about 1:1000. The surface molecular interaction mainly occurs on the inner particle surface.

Dr. Shulamit Levin, Medtechnica


levins@medtechnica.co.il

26

Reversed Phase HPLC

Pore Size
Most silica gel packings are porous
n

Silica Gel Pore Structure


100

* Silica is Porous * Pore Size, or nm -- distribution * Specific Pore Volume, mL/g Range: 0.3 -- 1.3 mL/g SV Particle Strength
Pore Size Recommendation 60 - 130 (6 - 13 nm) 100 (10 nm) 300 - 1,000 (30 - 100 nm) non- porous

>99% of the surface area is contained within the particle (not on the surface)-Where the chromatography happens.
The smaller the pore size, the greater the surface area. w (100 approx. 300 m2/gram) w (300 approx. 100 m2/gram)

Rules of Thumb

Analyte MW < 3,000 3,000 - 10,000 >10,000 Very Large

The greater the surface area, the greater the retention.

A typical 15 cm column holds a surface area of ~100-300 square meters

Exclusion Inclusion Effects


Ligand
R H
3

Pore Size Effects on Resolution


Conditions
Symmetry, C18, 5m, 4.6 X 150 mm, 100
0.30 10 56 23 1 4 7 9 8 11 12 13

R H
3 3

C Si

CH

C Si

CH
3

0.20 0.10 AU

Micropore 6
O

0.00
Si

Si

CH
3

H
3

-0.10 0.00

20.00 Minutes

40.00

- Sample: Tryptic digests of cytochrome c (bovine) - Injection: 20 L - Mobile Phase: Solvent A: 0.1% TFA in water Solvent B: 0.1% TFA in acetonitrile - Gradient: 0-50 min., 0-30%B - Temperature: 35 C - Flow Rate: 0.75 mL/min. - Detection: 214 nm

Si

CH
3

H
3

Si

O Si

O CH
3

H
3

Si

0.500 0.500
O

5,6 9 2 1 3
20.00

Symmetry300, C , 5 m, 4.6 X 150 mm, 300 10 13


18

O Si O

CH
3

CH
3

0.400 0.400 0.300 0.300 AU 0.200 0.200 0.100 0.100 0.000 0.000 0.00 Minutes

12 11

O Si Si

Si

4 7

- Different pore sizes change selectivity.

XTerra

Matrix

40.00

Carmody

Dr. Shulamit Levin, Medtechnica


levins@medtechnica.co.il

27

Reversed Phase HPLC


Mechanism of Retention of Polar Compounds on Aqueous Columns

Polarity/Aqueous Columns:
Low ligand density High pore volumn

Polar analytes are not able to Fit between ligands cant interact with surface
H3C CH 2 H2C CH 2 H2C H 2C H 2C H3C H O Si O CH 2 H 2C CH2 H 2C CH2 CH 2 H3C CH2 H 2C CH 2 H 2C H 3C CH 2 H 2C CH 2 H 3C CH 2

High Coverage High Ligand Density

CH 2 Endcap H2C H2 C Residual silanol H2 C CH2 CH2 CH 2 CH 3 CH 2 CH 3 3C H 3C H H 3 C H 3 C CH 3 H3 C CH 3 CH3 CH3 CH3 H Si CH 3 Si Si Si Si Si H H H H O H O O O O O O O O O O O Si Si Si Si Si Si Si Si Si Si O Si O O O O O O O O O O O O O O O O O O O O O

H3 C CH 2 H2 C CH 2 H2 C H 2C CH 2

C8 alkyl chains Polar analytes easily interact with surface Residual silanols

H 3C CH 2 H 2C CH 2 H 2C

Low Coverage Low Ligand Density

CH 2 CH 3 CH 3 H3C CH 3 H3 C Si CH 3 H CH3 H 3C Si Si H H H O O O O O O O Si Si Si Si Si Si Si O O O O O O O O O O O O O

H O O Si O

CH 2 H2C Endcap CH 2 CH 3 H3 C CH 3 H 3C Si CH 3 Si H H O H O O O O Si Si Si O O O O Si O O O O

Polar Compounds - Aqua Columns


Polar and Non -Polar Compounds Test Mix
Conditions Columns: 4.6 x 150 mm, 5 m Mobile Phase A: H2 O Mobile Phase B: ACN Mobile Phase C: 100 mM NH4 COOH, pH 3.0 Flow Rate: 2.0 mL/min Gradient: Time Profile (min) %A %B %C 0.0 80 10 10 10.0 0 95 5 15.0 0 95 5 Injection Volume: 5.0 L o Temperature: 30 C Detection: UV @ 254 nm
V0 = 0.98 min Compounds USP Tailing: 1. Uracil 1.04 2. Acetanilide 0.95 3. Triamcinolone 1.02 4. Hydrocortisone 1.03 5. 2-Amino-7-chloro -5-oxo -5H-[1]benzopyrano[2,3-b]pyridinecarbonitrile 1.01 6. 6a-Methyl -17a-hydroxyprogesterone 1.01 7. 3-Aminofluoranthene 0.97 8. 2-Bromofluorene 1.00 9. Perylene 0.99 10. Naphthol[2,3-a]pyrene 0.95

Chromolith Packing
By utilising an innovative new "Gel-Sol" technology, a silica gel polymer is formed, which after ageing, is dried into the required form of a straight rod of highly porous silica with a bimodal pore structure. Chromolith macroporestructure

Chromolith mesopore structure

7 9 8 6 10

3 4 5

Altantis dC 18

1.00

2.00

3.00

4.00

5.00

6.00

7.00 8.00 Minutes

9.00

10.00

11.00

12.00

13.00

14.00

15.00

Dr. Shulamit Levin, Medtechnica


levins@medtechnica.co.il

28

Reversed Phase HPLC


Batch-to-Batch Reproducibility of Columns
Columns: Symmetry C 83.9 mm X 150 mm with Sentry Guard Column 3.9 mm X 20 mm Sample: Mobile Phase: Barbiturate Standard 100 mM potassium phosphate, pH 6.9/acetonitrile/water 20:30:50 3: Sulfathiazole 2: Sulfadiazine

Chromatogram of lifetime test


Conditions

1: Sulfanilamide

1 2

3 4 5

Column:

Symmetry C

8 3.9 mm X 150 mm with Sentry Guard Column 3.9 mm X 20 mm

Mobile Phase: water/methanol/glacial acetic acid 79:20:1

4: Sulfamerazine

Batch A
2

Batch B Batch C
0 2 4 6 8 10 12 5: Sulfamethazine
1 0 2 4 6 8 10

Injection 5020
Start

Minutes

6: Succinylsulfathiazole

Minutes

Dr. Shulamit Levin, Medtechnica


levins@medtechnica.co.il

29

You might also like